PLoS ONEBioinformaticsPeer-reviewed journal article
PAH-former: Transfer Learning for Efficient Discovery of Pulmonary Arterial Hypertension-Associated Genes
Toshinaru KawakamiiD, Sosuke Hosokawa, Masamichi ItoiD, Atsumasa KurozumiiD, Ryohei Tanaka, Shun MinatsukiiD, Junichi IshidaiD, Takayuki IsagawaiD, Satoshi KoderaiD, Norihiko Takeda
Abstract
Single-cell RNA sequencing (scRNA-seq) of patient samples holds promise for understanding disease mechanisms, but faces the challenge of excessive cost and effort in acquisition, processing, and data analysis, making it essential to leverage existing data. Pulmonary artery hypertension (PAH) is a refractory disease characterized by pulmonary vascular remodeling, and access to patient specimens is limited due to difficulties in tissue collection. In this study, we employed transfer learning with Geneformer, a deep learning algorithm pre-trained with scRNA-seq datasets and fine-tuned it with public PAH lung tissue data to identify the disease-relevant genes. The resulting algorithm, which we named PAH- former, demonstrated that its prediction accuracy varied significantly depending on the dataset used for fine-tuning. PAH-former enabled us to perform in silico perturbation analysis and identified PAH related genes. Loss-of-function PAH related genes in human pulmonary artery endothelial cells increased the expression of SOX18, a signature gene of PAH. This integration of artificial intelligence and biological experiments can significantly advance our understanding of molecular mechanisms of PAH.
- organism: human
- assay: scRNA-seq
- research focus: gene regulatory network inference
- research focus: differential expression
- research focus: benchmarking
- approach: deep learning
- approach: statistical model
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 12th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Single-cell transcriptomics reveal diverging pathobiology and opportunities for precision targeting in scleroderma-associated versus idiopathic pulmonary arterial hypertension
Tijana Tuhy, Julie C. Coursen, … Catherine E. Simpson·bioRxiv·Oct 25, 2024
- Emergence of disease-specific endothelial and stromal cell populations responsible for arterial remodeling during development of pulmonary arterial hypertension
Nicholas D Cober, Emma R. McCourt, … Duncan John Stewart·bioRxiv·Sep 6, 2023
- Identification of drug candidates for rescue of SOX17 gene targets in pulmonary arterial hypertension
Eleni Vasilaki, Bedia Akosman, … Christopher J. Rhodes·bioRxiv·May 21, 2026
- Machine learning-based revelation of GABBR1 and IQGAP2 as candidate biomarkers of pulmonary arterial hypertension and their correlation with immune infiltration
Bao Wang, Ju Cheng, … Yanfeng Peng·bioRxiv·Oct 27, 2023
- General Capillary Endothelial Cells Undergo Reprogramming into Arterial Endothelial Cells in Pulmonary Hypertension through HIF-2α/Notch4 Pathway
B. Liu, D. Yi, … Z. Dai·CirculationPeer-reviewed·Jul 30, 2024
- Pulmonary Hypertension Engine for Linked Experiments (PHELEX): a platform for the re-analysis of public transcriptomic data related to pulmonary hypertension in both animal models, and humans.
Tanvi Nandani, Benjamin P. Ott, … Charles C.T. Hindmarch·bioRxiv·May 1, 2026